Company updateMoneycontrol
Motilal Oswal sets Glenmark Pharma target at Rs 3000
Positive+5
GreyOak summary
Motilal Oswal upgraded Glenmark Pharma to a Buy rating with a target price of Rs 3,000. The broker values the stock at 26x forward earnings, citing superior execution in key segments.
What it affects
- Glenmark PharmaceuticalsGLENMARKPositive +5
Target price raised to Rs 3000Rolling sentiment Negative -54
Source
Read the original at MoneycontrolMore Glenmark Pharmaceuticals news
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Pharma stocks rally: Aurobindo, Divi's, Glenmark, Symbiotec hit new highsBusiness Standard · Stock view ·
- Glenmark Pharma shares fall 4% after Q2 profit plunges 57%Business Today · Results ·
- Glenmark Pharma shares react to better-than-expected US sales in Q2CNBC-TV18 · Results ·
- Titan, Bharti, Britannia, Glenmark, Godfrey, NCC, KNR, Ashoka focusMoneycontrol · Stock view ·